{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000138","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.850353+00:00","generated_at":"2026-05-31T02:14:22.356908+00:00","sec_items":["5.02","5.08"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lifecore Biomedical announces two director departures, Nov 7 annual meeting","bullets":["Jeffrey L. Edwards will not stand for re-election; Ray Diradoorian resigns effective before 2024 annual meeting.","Both directors said their decisions were not due to any disagreement with the company.","Annual meeting set for November 7, 2024; shareholder proposals due by October 3, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000138","json":"https://secwatch.observer/filing/0001005286-24-000138.json","markdown":"https://secwatch.observer/filing/0001005286-24-000138.md","text":"https://secwatch.observer/filing/0001005286-24-000138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000138/0001005286-24-000138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000138/lndc-20240923.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:14:22.356908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58f9087dfb","claim":"Jeffrey L. Edwards departed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Jeffrey L. Edwards notified Lifecore Biomedical, Inc. (the “Company”) that he has elected not to stand for re-election to serve as a director of the Board of Directors of the Company (the “Board”) at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000138/0001005286-24-000138-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not standing for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ad15fca4b3","claim":"Ray Diradoorian departed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Ray Diradoorian notified the Company that he intends to resign as a director of the Board effective as of immediately prior to the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000138/0001005286-24-000138-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}